Instructions for Diabeton (Gliclazide) 60 mg 30 pills
English product name Gliclazide
Diabeton® MR
Release Form
Table with modified release 60 mg: 30 or 60 pcs
Table with modified release 60 mg: 28, 30 or 60 pcs.
Description Diabeton
The modified release pills are white, double-convex, oval with a serration and "DIA" "60" etched on both sides.
1 tab.
glyclazide 60 mg
Auxiliary substances: lactose monohydrate, maltodextrin, hypromellose 100 cP, magnesium stearate, silicon dioxide colloidal anhydrous.
30 pcs. - blister packs (1) - cardboard packs with first opening control (if necessary).
30 pcs. - blister packs (2) - cardboard packs with first opening control (if necessary).
ATC codes
A10BB09 Gliclazide
Clinical-pharmacological groups / Group affiliation
Oral hypoglycemic preparation of the sulfonyl urea group of generation II
Active substance
glyclazide
Pharmaco-therapeutic group Diabeton
Hypoglycemic agent for the oral administration of a group of sulfonyl urea of generation II
Storage Conditions Gliclazide
The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.
Best before date
The shelf life is two years. Do not use after the expiry date specified on the package.
Testimony Diabeton
type 2 diabetes with insufficient efficiency of diet therapy, physical exertion and reduction of body weight;
prevention of complications of diabetes mellitus: reduction of the risk of microvascular (nephropathy, retinopathy) and macrovascular complications (myocardial infarction, stroke) in patients with type 2 diabetes through intensive glycemic control.
Method of use, course and dosage Diabeton
- Glyclazide is intended only for the treatment of adults.
- The recommended dose of the drug should be taken once a day, preferably during breakfast.
- The daily dose may be 30-120 mg (1/2-2 tabb.) per dose.
- It is recommended to swallow a tablet or half of the tablet whole, not chewing or chopping.
- If you miss one or more of the drug's shots, you cannot take a higher dose the next time you take it, you should take the next day.
- As with other hypoglycemic medicines, the dose of the drug in each case must be selected individually, depending on blood
- glucose concentration and HbA1c.
Pharmacological effect Diabeton
Glyclazide is a sulfonyl urea derivative, a hypoglycemic oral preparation that differs from similar drugs in that it has an N-containing heterocyclic ring with an endocyclic bond.
Glyclazide reduces blood glucose concentration by stimulating insulin secretion by β cells on the islets of Langerhans.
- Nosology Gliclazide (ICD codes)
- E11
- Type 2 diabetes
- E11.6
- Insulin-independent diabetes mellitus with other specified complications
- H36.0
- Diabetic retinopathy
- I79.2
- Peripheral angiopathy for diseases classified in other headings (including diabetic angiopathy)
- N08.3
- Glomerular Diabetes Lesions
